Artikel

Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).

Think Fabry, think timely testing first.

Think Fabry, think regular profile-based assessments.

Cardiovascular disease is the leading cause of death in Fabry disease patients.¹ Undiagnosed and untreated Fabry disease leads to progressive, irreversible, life-threatening heart injury.^2,3

Think Fabry, think renal involvement that may present early in life and could go undetected.

Think Fabry, think screening at-risk family members.¹

Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.^1,2

Beneath the skin of patients with AD—type 2 inflammation and the cytokines involved.

Being diagnosed with type 1 diabetes at the age of 18 is a life-altering experience for most people. But when, like Lucas, you receive three other diagnoses within a few months, it can feel overwhelming. Living with type 1 diabetes becomes even more challenging when you also have autism.

Three years ago, Tina’s 13-year-old son was diagnosed with type 1 diabetes. It was a harrowing ordeal, as he was rushed to the hospital with severe diabetic ketoacidosis. Even today, the entire family remains deeply affected by the traumatic experience.